Fairvalue-Calculator Fairvalue-Calculator
EN DE

Avanos Medical, Inc (AVNS) Fair Value & Analysis

Healthcare · US · Market cap $1.2B

Price$24.93
Fair Value$8.72
Upside-65.0%
Quality95/100
Evidence: Medium Range $6.76 – $11.03

Fair value as of: Jun 24, 2026

Analysis

Avanos Medical, Inc (AVNS) currently trades at $24.93, while our model-based Fair Value estimate is $8.72 — implying the stock looks roughly 65.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, In…

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Avanos Medical, Inc (AVNS) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $8.72 versus a price of $24.93 — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AVNS?
Our 21-model fair value for Avanos Medical, Inc is $8.72 (as of Jun 24, 2026), built from audited fundamentals. The current price is $24.93.
What is the quality score of AVNS?
Avanos Medical, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.